Protein export systems of Mycobacterium tuberculosis: Novel targets for drug development?

Future Microbiology

Volumn 5, Issue 10, 2010, Pages 1581-1597

  Feltcher, Meghan E ^a   Sullivan, Jonathan Tabb ^a   Braunstein, Miriam ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

drug target; ESX; mycobacteria; protein export; Sec; SecA2; secretion; Tat; tuberculosis

Indexed keywords

ARGININE; BACTERIAL PROTEIN; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; PROTEIN ESX1; PROTEIN ESX3; PROTEIN SECA2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SEQUENCE ANALYSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MYCOBACTERIUM TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 78449263722     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.112     Document Type: Review

References (122)

1. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009. WHO Press, Geneva, Switzerland. Publication no. WHO/HTM/TB/2009.411 (2009).
2. Russell DG: Mycobacterium tuberculosis: life and death in the phagosome. In: Handbook of Tuberculosis: Molecular biology and Biochemistry. Kaufmann SH, Rubin EJ (Eds). Wiley-VCH, 307-322 (2008).
3. Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H: Mycobacterial outer membranes: in search of proteins. Trends Microbiol. 18(3), 109-116 (2010).
4. Hoffmann C, Leis A, Niederweis M, Plitzko JM, Engelhardt H: Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl Acad. Sci. USA 105(10), 3963-3967 (2008).
5. Zuber B, Chami M, Houssin C, Dubochet J, Griffths G, Daffe M: Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 190(16), 5672-5680 (2008).
6. Lemassu A, Daffe M: Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J. 297 (Pt 2), 351-357 (1994).
7. Schneider G: How many potentially secreted proteins are contained in a bacterial genome? Gene 237, 1113-1121 (1999).
8. Natale P, Bruser T, Driessen AJ: Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane - distinct translocases and mechanisms. Biochim. Biophys. Acta 1778(9), 1735-1756 (2008).
9. Papanikou E, Karamanou S, Economou A: Bacterial protein secretion through the translocase nanomachine. Nat. Rev. Microbiol. 5(11), 839-851 (2007).
10. Brundage L, Hendrick JP, Schiebel E, Driessen AJ, Wickner W: The purifed E. coli integral membrane protein SecY/E is suffcient for reconstitution of SecA-dependent precursor protein translocation. Cell 62(4), 649-657 (1990).
11. Economou A, Wickner W: SecA promotes preprotein translocation by undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell 78(5), 835-843 (1994).
12. Braun V, Wu HC: Lipoproteins, structure, function, biosynthesis and models for protein export. In: Bacterial Cell Wall. Ghuysen M, Hakenback R (Eds). Elsevier, Amsterdam, The Netherlands 319-342 (1993).
13. Paetzel M, Karla A, Strynadka NC, Dalbey RE: Signal peptidases. Chem. Rev. 102(12), 4549-4580 (2002).
14. Xie K, Dalbey RE: Inserting proteins into the bacterial cytoplasmic membrane using the Sec and YidC translocases. Nat. Rev. Microbiol. 6(3), 234-244 (2008).
15. Du Plessis DJ, Berrelkamp G, Nouwen N, Driessen AJ: The lateral gate of SecYEG opens during protein translocation. J. Biol. Chem. 284(23), 15805-15814 (2009).
16. Sander P, Rezwan M, Walker B et al.: Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 52(6), 1543-1552 (2004).
17. Rampini SK, Selchow P, Keller C, Ehlers S, Bottger EC, Sander P: LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest. Microbiology 154(Pt 10), 2991-3001 (2008).
18. Braunstein M, Brown AM, Kurtz S, Jacobs WR Jr.: Two nonredundant SecA homologues function in mycobacteria. J. Bacteriol. 183(24), 6979-6990 (2001).
19. Guo X V, Monteleone M, Klotzsche M et al.: Silencing essential protein secretion in Mycobacterium smegmatis using tetracycline repressors. J. Bacteriol. 189(13), 4614-4623 (2007).
20. Sassetti CM, Boyd DH, Rubin EJ: Comprehensive identifcation of conditionally essential genes in mycobacteria. Proc. Natl Acad. Sci. USA 98(22), 12712-12717 (2001).
21. Rigel NW, Gibbons HS, McCann JR, McDonough JA, Kurtz S, Braunstein M: The accessory SecA2 system of mycobacteria requires ATP binding and the canonical SecA1. J. Biol. Chem. 284(15), 9927-9936 (2009).
22. Rigel NW, Braunstein M: A new twist on an old pathway - accessory Sec [corrected] systems. Mol. Microbiol. 69(2), 291-302 (2008).
23. Caspers M, Freudl R: Corynebacterium glutamicum possesses two SecA homologous genes that are essential for viability. Arch. Microbiol. 189(6), 605-610 (2008).
24. Bensing BA, Sullam PM: An accessory Sec locus of Streptococcus gordonii is required for export of the surface protein GspB and for normal levels of binding to human platelets. Mol. Microbiol. 44(4), 1081-1094 (2002).
25. Chen Q, Wu H, Fives-Taylor PM: Investigating the role of SecA2 in secretion and glycosylation of a fmbrial adhesin in Streptococcus parasanguis FW213. Mol. Microbiol. 53(3), 843-856 (2004).
26. Siboo IR, Chaffn DO, Rubens CE, Sullam PM: Characterization of the accessory Sec system of Staphylococcus aureus. J. Bacteriol. 190(18), 6188-6196 (2008).
27. Lenz LL, Mohammadi S, Geissler A, Portnoy DA: SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc. Natl Acad. Sci. USA 100(21), 12432-12437 (2003).
28. Mistou MY, Dramsi S, Brega S, Poyart C, Trieu-Cuot P: Molecular dissection of the SecA2 locus of group B streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J. Bacteriol. 191(13), 4195-4206 (2009).
29. Bensing BA, Takamatsu D, Sullam PM: Determinants of the streptococcal surface glycoprotein GspB that facilitate export by the accessory Sec system. Mol. Microbiol. 58(5), 1468-1481 (2005).
30. Chen Q, Sun B, Wu H, Peng Z, Fives-Taylor PM: Differential roles of individual domains in selection of secretion route of a Streptococcus parasanguinis serine-rich adhesin, Fap1. J. Bacteriol. 189(21), 7610-7617 (2007).
31. Bensing BA, Siboo IR, Sullam PM: Glycine residues in the hydrophobic core of the GspB signal sequence route export toward the accessory Sec pathway. J. Bacteriol. 189(10), 3846-3854 (2007).
32. Braunstein M, Espinosa B, Chan J, Belisle JT, Jacobs WRJ: SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 48(2), 453-464 (2003).
33. Burkholder KM, Kim KP, Mishra KK et al.: Expression of Lap, a SecA2-dependent secretory protein, is induced under anaerobic environment. Microbes Infect. 11(10-11), 859-867 (2009).
34. Gibbons HS, Wolschendorf F, Abshire M, Niederweis M, Braunstein M: Identifcation of two Mycobacterium smegmatis lipoproteins exported by a SecA2-dependent pathway. J. Bacteriol. 189(14), 5090-5100 (2007).
35. Archambaud C, Nahori MA, Pizarro-Cerda J, Cossart P, Dussurget O: Control of Listeria superoxide dismutase by phosphorylation. J. Biol. Chem. 281(42), 31812-31822 (2006).
36. Sadagopal S, Braunstein M, Hager CC et al.: Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. PLoS One 4(5), E5531 (2009).
37. Kurtz S, Mckinnon K P, Runge MS, Ting JP, Braunstein M: The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response. Infect. Immun. 74(12), 6855-6864 (2006).
38. Hou JM, D'lima NG, Rigel NW et al.: ATPase activity of Mycobacterium tuberculosis SecA1 and SecA2 proteins and its importance for SecA2 function in macrophages. J. Bacteriol. 190(14), 4880-4887 (2008).
39. Hinchey J, Lee S, Jeon BY et al.: Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Invest. 117(8), 2279-2288 (2007).
40. Dilks K, Rose RW, Hartmann E, Pohlschroder M: Prokaryotic utilization of the twin-arginine translocation pathway: a genomic survey. J. Bacteriol. 185(4), 1478-1483 (2003).
41. Lee PA, Tullman-Ercek D, Georgiou G: The bacterial twin-arginine translocation pathway. Annu. Rev. Microbiol. 60, 373-395 (2006).
42. Stanley NR, Palmer T, Berks BC: The twin arginine consensus motif of Tat signal peptides is involved in Sec-independent protein targeting in Escherichia coli. J. Biol. Chem. 275(16), 11591-11596 (2000).
43. Luke I, Handford JI, Palmer T, Sargent F: Proteolytic processing of Escherichia coli twin-arginine signal peptides by LepB. Arch. Microbiol. 191(12), 919-925 (2009).
44. Gimenez MI, Dilks K, Pohlschroder M: Haloferax volcanii twin-arginine translocation substates include secreted soluble, C-terminally anchored and lipoproteins. Mol. Microbiol. 66(6), 1597-1606 (2007).
45. Hatzixanthis K, Palmer T, Sargent F: A subset of bacterial inner membrane proteins integrated by the twin-arginine translocase. Mol. Microbiol. 49(5), 1377-1390 (2003).
46. Delisa MP, Tullman D, Georgiou G: Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc. Natl Acad. Sci. USA 100(10), 6115-6120 (2003).
47. Tullman-Ercek D, Delisa MP, Kawarasaki Y et al.: Export pathway selectivity of Escherichia coli twin-arginine translocation signal peptides. J. Biol. Chem. 282(11), 8309-8316 (2007).
48. De Buck E, Lammertyn E, Anne J: The importance of the twin-arginine translocation pathway for bacterial virulence. Trends Microbiol. 16(9), 442-453 (2008).
49. Ochsner UA, Snyder A, Vasil AI, Vasil ML: Effects of the twin-arginine translocase on secretion of virulence factors, stress response, and pathogenesis. Proc. Natl Acad. Sci. USA 99(12), 8312-8317 (2002).
50. De Buck E, Maes L, Meyen E et al.: Legionella pneumophila Philadelphia-1 TatB and TatC affect intracellular replication and bioflm formation. Biochem. Biophys. Res. Commun. 331(4), 1413-1420 (2005).
51. Rossier O, Cianciotto NP: The Legionella pneumophila TatB gene facilitates secretion of phospholipase C, growth under iron-limiting conditions, and intracellular infection. Infect. Immun. 73(4), 2020-2032 (2005).
52. Saint-Joanis B, Demangel C, Jackson M et al.: Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases b-lactam susceptibility and virulence. J. Bacteriol. 188(18), 6669-6679 (2006).
53. Mcdonough JA, Hacker KE, Flores AR, Pavelka MS Jr, Braunstein M: The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial b-lactamases. J. Bacteriol. 187(22), 7667-7679 (2005).
54. Posey JE, Shinnick TM, Quinn FD: Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis. J. Bacteriol. 188(4), 1332-1340 (2006).
55. Marrichi M, Camacho L, Russell DG, Delisa MP: Genetic toggling of alkaline phosphatase folding reveals signal peptides for all major modes of transport across the inner membrane of bacteria. J. Biol. Chem. 283(50), 35223-35235 (2008).
56. McDonough JA, McCann JR, Tekippe EM, Silverman JS, Rigel N W, Braunstein M: Identifcation of functional Tat signal sequences in Mycobacterium tuberculosis proteins. J. Bacteriol. 190(19), 6428-6438 (2008).
57. Ferrandez Y, Condemine G: Novel mechanism of outer membrane targeting of proteins in Gram-negative bacteria. Mol. Microbiol. 69(6), 1349-1357 (2008).
58. Raynaud C, Guilhot C, Rauzier J et al.: Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 45(1), 203-217 (2002).
59. Abdallah AM, Gey Van Pittius NC, Champion PA et al.: Type VII secretion - mycobacteria show the way. Nat. Rev. Microbiol. 5(11), 883-891 (2007).
60. Brodin P, Majlessi L, Marsollier L et al.: Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect. Immun. 74(1), 88-98 (2006).
61. Guinn KM, Hickey MJ, Mathur SK et al.: Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51(2), 359-370 (2004).
62. Hsu T, Hingley-Wilson SM, Chen B et al.: The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl Acad. Sci. USA 100(21), 12420-12425 (2003).
63. Ohol YM, Goetz DH, Chan K, Shiloh MU, Craik CS, Cox JS: Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe 7(3), 210-220 (2010).
64. Stanley SA, Raghavan S, Hwang W W, Cox JS: Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc. Natl Acad. Sci. USA 100(22), 13001-13006 (2003).
65. Fortune SM, Jaeger A, Sarracino DA et al.: Mutually dependent secretion of proteins required for mycobacterial virulence. Proc. Natl Acad. Sci. USA 102(30), 10676-10681 (2005).
66. Macgurn JA, Raghavan S, Stanley SA, Cox JS: A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis. Mol. Microbiol. 57(6), 1653-1663 (2005).
67. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46(3), 709-717 (2002).
68. Lewis KN, Liao R, Guinn KM et al.: Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J. Infect. Dis. 187(1), 117-123 (2003).
69. Mclaughlin B, Chon JS, Macgurn JA et al.: A mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog. 3(8), e105 (2007).
70. Gao LY, Guo S, Mclaughlin B, Morisaki H, Engel JN, Brown EJ: A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53(6), 1677-1693 (2004).
71. Macgurn JA, Cox JS: A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifes components of the ESX-1 secretion system. Infect. Immun. 75(6), 2668-2678 (2007).
72. Xu J, Laine O, Masciocchi M et al.: A unique mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol. Microbiol. 66(3), 787-800 (2007).
73. De Jonge MI, Pehau-Arnaudet G, Fretz MM et al.: ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J. Bacteriol. 189(16), 6028-6034 (2007).
74. Derrick SC, Morris SL: The ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression. Cell Microbiol. 9(6), 1547-1555 (2007).
75. Smith J, Manoranjan J, Pan M et al.: Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect. Immun. 76(12), 5478-5487 (2008).
76. Van Der Wel N, Hava D, Houben D et al.: M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129(7), 1287-1298 (2007).
77. Davis JM, Ramakrishnan L: The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136(1), 37-49 (2009).
78. Serafni A, Boldrin F, Palu G, Manganelli R: Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc. J. Bacteriol. 191(20), 6340-6344 (2009).
79. Siegrist MS, Unnikrishnan M, Mcconnell MJ et al.: Mycobacterial ESX-3 is required for mycobactin-mediated iron acquisition. Proc. Natl Acad. Sci. USA 106(44), 18792-18797 (2009).
80. Sassetti CM, Boyd DH, Rubin EJ: Genes required for mycobacterial growth defned by high density mutagenesis. Mol. Microbiol. 48(1), 77-84 (2003).
81. Sassetti CM, Rubin EJ: Genetic requirements for mycobacterial survival during infection. Proc. Natl Acad. Sci. USA 100(22), 12989-12994 (2003).
82. Abdallah AM, Verboom T, Hannes F et al.: A specifc secretion system mediates PPE41 transport in pathogenic mycobacteria. Mol. Microbiol. 62(3), 667-679 (2006).
83. Abdallah AM, Verboom T, Weerdenburg EM et al.: PPE and PE-PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol. Microbiol. 73(3), 329-340 (2009).
84. Bitter W, Houben EN, Bottai D et al.: Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog. 5(10), E1000507 (2009).
85. Brodin P, De Jonge MI, Majlessi L et al.: Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J. Biol. Chem. 280(40), 33953-33959 (2005).
86. Champion PA, Stanley SA, Champion MM, Brown EJ, Cox JS: C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science 313(5793), 1632-1636 (2006).
87. Raghavan S, Manzanillo P, Chan K, Dovey C, Cox JS: Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 454(7205), 717-721 (2008).
88. Digiuseppe Champion PA, Champion MM, Manzanillo P, Cox JS: ESX-1 secreted virulence factors are recognized by multiple cytosolic AAA ATPases in pathogenic mycobacteria. Mol. Microbiol. 73(5), 950-962 (2009).
89. Luthra A, Mahmood A, Arora A, Ramachandran R: Characterization of Rv3868, an essential hypothetical protein of the ESX-1 secretion system in Mycobacterium tuberculosis. J. Biol. Chem. 283(52), 36532-36541 (2008).
90. Krogh A, Larsson B, Von Heijne G, Sonnhammer EL: Predicting transmembrane protein topology with a hidden markov model: application to complete genomes. J. Mol. Biol. 305(3), 567-580 (2001).
91. Dave JA, Gey Van Pittius NC, Beyers AD, Ehlers MR, Brown GD: Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages. BMC Microbiol. 2(1), 30 (2002).
92. Haney SA, Alksne LE, Dunman PM, Murphy E, Projan SJ: Genomics in anti-infective drug discovery - getting to endgame. Curr. Pharm. Des. 8(13), 1099-1118 (2002).
93. Escaich S: Antivirulence as a new antibacterial approach for chemotherapy Curr. Opin. Chem. Biol. 12(4), 400-408 (2008).
94. Misra S, Silhavy TJ: Protein secretion in bacteria: a chemotherapeutic target? In: Emerging Targets in Antibacterial and Antifungal Chemotherapy. Sutcliffe J, Georgopapadakou NH (Eds.). Chapman and Hall, NY, USA 164-176 (1992).
95. Baron C: Antivirulence drugs to target bacterial secretion systems. Curr. Opin. Microbiol. 13(1), 100-105 (2010).
96. Alksne LE, Burgio P, Hu W et al.: Identifcation and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system. Antimicrob. Agents Chemother. 44(6), 1418-1427 (2000).
97. Van Stelten J, Silva F, Belin D, Silhavy TJ: Effects of antibiotics and a proto-oncogene homolog on destruction of protein translocator SecY. Science 325(5941), 753-756 (2009).
98. Li M, Huang YJ, Tai PC, Wang B: Discovery of the frst SecA inhibitors using structure-based virtual screening. Biochem. Biophys. Res. Commun. 368(4), 839-845 (2008).
99. Chen W, Huang YJ, Gundala SR et al.: The frst low μ M SecA inhibitors. Bioorg Med. Chem. 18(4), 1617-1625 (2010).
100. Parish CA, De La Cruz M, Smith SK et al.: Antisense-guided isolation and structure elucidation of pannomycin, a substituted cis-decalin from Geomyces pannorum. J. Nat. Prod. 72(1), 59-62 (2009).
101. Sugie Y, Inagaki S, Kato Y et al.: CJ-21,058, a new SecA inhibitor isolated from a fungus. J. Antibiot. 55(1), 25-29 (2002).
102. Paetzel M, Dalbey RE, Strynadka NC: The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target. Pharmacol. Ther. 87(1), 27-49 (2000).
103. Date T: Demonstration by a novel genetic technique that leader peptidase is an essential enzyme of Escherichia coli. J. Bacteriol. 154(1), 76-83 (1983).
104. Cregg KM, Wilding I, Black MT: Molecular cloning and expression of the spsB gene encoding an essential type I signal peptidase from Staphylococcus aureus. J. Bacteriol. 178(19), 5712-5718 (1996).
105. Allsop A, Brooks G, Edwards PD, Kaura AC, Southgate R: Inhibitors of bacterial signal peptidase: A series of 6-(substituted oxyethyl)penems. J. Antibiot. 49(9), 921-928 (1996).
106. Black MT, Bruton G: Inhibitors of bacterial signal peptidases. Curr. Pharm. Des. 4(2), 133-154 (1998).
107. Harris DA, Powers ME, Romesberg FE: Synthesis and biological evaluation of penem inhibitors of bacterial signal peptidase. Bioorg. Med. Chem. Lett. 19(14), 3787-3790 (2009).
108. Schimana J, Gebhardt K, Holtzel A et al.: Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tu 6075. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. 55(6), 565-570 (2002). (Pubitemid 34752601)
109. Roberts TC, Smith PA, Cirz RT, Romesberg FE: Structural and initial biological analysis of synthetic arylomycin A2. J. Am. Chem. Soc. 129(51), 15830-15838 (2007).
110. Dev IK, Harvey RJ, Ray PH: Inhibition of prolipoprotein signal peptidase by globomycin. J. Biol. Chem. 260(10), 5891-5894 (1985).
111. Kiho T, Nakayama M, Yasuda K, Miyakoshi S, Inukai M, Kogen H: Structure- activity relationships of globomycin analogues as antibiotics. Bioorg. Med. Chem. 12(2), 337-361 (2004).
112. Galan JE, Collmer A: Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284(5418), 1322-1328 (1999).
113. Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M: Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10(3), 241-249 (2003). (Pubitemid 36380281)
114. Nordfelth R, Kauppi AM, Norberg HA, Wolf-Watz H, Elofsson M: Small-molecule inhibitors specifcally targeting type III secretion. Infect. Immun. 73(5), 3104-3114 (2005).
115. Wolf K, Betts HJ, Chellas-Gery B, Hower S, Linton CN, Fields KA: Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61(6), 1543-1555 (2006).
116. Aiello D, Williams JD, Majgier-Baranowska H et al.: Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. Antimicrob. Agents Chemother. 54(5), 1988-1999 (2010).
117. Sardis MF, Economou A: SecA: a tale of two protomers. Mol. Microbiol. 76(5), 1070-1081 (2010).
118. Sharma V, Arockiasamy A, Ronning DR et al.: Crystal structure of Mycobacterium tuberculosis SecA, a preprotein translocating ATPase. Proc. Natl Acad. Sci. USA 100(5), 2243-2248 (2003). (Pubitemid 36297484)
119. McCann JR, McDonough JA, Pavelka MS, Braunstein M: b-lactamase can function as a reporter of bacterial protein export during Mycobacterium tuberculosis infection of host cells. Microbiology 153(Pt 10), 3350-3359 (2007).
120. Flores AR, Parsons LM, Pavelka MS Jr: Genetic analysis of the b-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to b-lactam antibiotics. Microbiology 151(Pt 2), 521-532 (2005).
121. Banaiee N, Jacobs WR, Ernst JD: LspA-independent action of globomycin on Mycobacterium tuberculosis. J. Antimicrob. Chemother. 60(2), 414-416 (2007).
122. Sargent F: The twin-arginine transport system: moving folded proteins across membranes. Biochem. Soc. Trans 35(Pt 5), 835-847 (2007).